Type 1 Diabetes, Progress With Stem Cells And Other Cell-Based Therapies – Seeking Alpha (registration)
|
Type 1 Diabetes, Progress With Stem Cells And Other Cell-Based Therapies
Seeking Alpha (registration) Novo Nordisk focuses on delaying the onset of Type 1 diabetes while paying attention to advances in stem cell technologies. AstraZeneca partners with Harvard researchers on insulin-producing beta cells derived from human stem cells. Stem Cell Therapy Promising for Type 2 Diabetes AstraZeneca and Harvard Partner on Stem Cell Therapies for Diabetes |
